Download FREE Report Sample
Download Free sampleLevothyroxine is?used to treat an underactive thyroid gland (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery.
Oral Levothyroxine Sodium Market contains market size and forecasts of Oral Levothyroxine Sodium in global, including the following market information:
Global Oral Levothyroxine Sodium Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Oral Levothyroxine Sodium Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Oral Levothyroxine Sodium companies in 2022 (%)
The global Oral Levothyroxine Sodium market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
25 mcg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oral Levothyroxine Sodium include Abbvie, Mylan Pharma, Merck, Pfizer, Lannett Company, Novartis, IBSA, Piramal Critical Care and Abbott. etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Levothyroxine Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Levothyroxine Sodium Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, by Type, 2022 (%)
25 mcg
50 mcg
75 mcg
Others
Global Oral Levothyroxine Sodium Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Others
Global Oral Levothyroxine Sodium Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Oral Levothyroxine Sodium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Levothyroxine Sodium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral Levothyroxine Sodium revenues share in global market, 2022 (%)
Key companies Oral Levothyroxine Sodium sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral Levothyroxine Sodium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Mylan Pharma
Merck
Pfizer
Lannett Company
Novartis
IBSA
Piramal Critical Care
Abbott
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
